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278 Developing patient resources for lung transplantation
S. Phillips1, C. Addy1, K. Bateman1, N.J. Bell1. 1University Hospitals Bristol
NHS Foundation Trust, Bristol Adult CF Centre, Bristol, United Kingdom
Aims: With advances in medical treatment, people with CF are living longer.
However, CF remains a life-limiting condition with lung transplantation as a
treatment option as health declines. To improve care of patients, patient resources
were developed to improve patient understanding of the transplant process and
optimise pre-listing counselling.
Methods: Three patient information resources were developed.
1. Transplant information leaﬂet: containing clear basic information about the
transplant process itself and how this decision is made, and a discussion of
the potential psychological dilemmas that people face and support available.
2. Post-transplant patients and CF MDT team members developed a document
based on patients’ experiences on the transplant ward, highlighting differences
between their regular ward in the CF Centre and the ward at the transplant centre.
This is particularly important for patients with CF who are ‘expert patients’ and
are often very involved in their own treatments and treatment choices.
3. ‘This is me’ leaﬂet which patients complete and take to the transplant centre. This
contains key information, including contact details and non-medical information,
which will help the people caring for them at transplant.
Conclusion: These resources aim to ensure that all CF patients are informed about
the lung transplantation process and that those undergoing assessment and listing
are prepared for differences in their care in the transplant clinic/ward, making the
process less distressing for patients who are already in a very stressful situation.
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Objectives: After lung transplantation, cystic ﬁbrosis patients have a lot of new
skills to acquire and some are essential for patient’s safety, particularly before the
ﬁrst return home.
Methods: In 2009, we elaborated a referential of skills, both for the immediate post-
operative period and the long-term follow-up (ECFS Dublin 2012). We identiﬁed
in the list twenty essential objectives that must be acquired by all patients, during
educative sessions. Generally, patient education begins around the 15th day after
transplantation, after the reanimation period. Patients begin to ask questions about
their new medications, diet, hygiene etc. About ﬁfteen days later, patients are ready
to go back home for the ﬁrst time, it is the moment to assess that they have reached
all the essential objectives. For that, we built a questionnaire which includes 9
True/False questions with degrees of certitude and four multiple-choice questions.
Questions essentially relate to the modalities of taking medications, adherence to
treatment, the emergency situations but also the prevention. The multiple-choice
questions relate to their daily life.
Results: Patients must correctly answer the questions before they ﬁrst return home.
In case of errors, new educative sessions will be organized to ensure patients’ safety.
The questionnaire is now used in most French transplantation units. Both patients
and health-care givers are satisﬁed.
Conclusion: The safety of recently transplanted patients for cystic ﬁbrosis before
the ﬁrst return home can be assessed by a short questionnaire. It is easy to ﬁll and
can be quickly analyzed by health-care professionals.
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Germany; 4CF Centre Hamburg-Altona, Hamburg, Germany; 5Hannover Medical
School, Dept of Pediatric Pulmonology and Neonatology, Hannover, Germany;
6Centre for Quality and Management in the Health-Care-System, Hannover,
Germany; 7CF Centre, University Hospital of Frankfurt, Frankfurt, Germany;
8Center for Health Economics Research Hannover, Hannover, Germany
Objectives: Cystic Fibrosis (CF) care requires a multi-professional team approach
including psychosocial services. VEMSE-CF is a comprehensive care program
integrating medical and psychosocial interventions. To determine the speciﬁc needs
for supportive psychosocial interventions all patients were screened for co-morbid
behavioral and emotional symptoms.
Methods: 151 CF-patients 6-years or older were recruited in three CF-out-patient
clinics and will be followed up for two years. Patients from other CF centres
receiving usual care and matched for sex, age and lung-function were identiﬁed as
controls. At the time of recruitment, patients 6−13 years were screened with the
Strengths and Difﬁculties Questionnaire (SDQ parent form) and patients 14 years
were screened with the Hospital Anxiety and Depression Scale (HADS).
Results: The baseline characteristics for the 151 participants in the intervention
group (73 female; FEV-1 % pred.: 70.3±27.3; Median BMI: 19.2) suggest that
a cohort representative of the German CF-population has been selected. Among
48 pediatric patients with CF, 20.9% showed elevated symptoms on the problem
score of the SDQ. Among 98 adolescent and adult patients, 30.6% showed elevated
symptoms of anxiety and 18.4% showed elevated symptoms of depression.
Conclusion: Between 20 and 30% of the study participants showed elevated
behavioral and/or emotional symptoms at baseline and were offered additional
psychosocial care within the program. Follow-up assessments will evaluate the
effect of the comprehensive care model on psychosocial outcomes.
This study is co-funded by the German Ministry of Health and the German CF-
association Mukoviszidose e.V.
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Objectives: Identify the core patient-centered outcomes in CF research.
Methods: Italian Patient Centered Outcomes Research (IPaCOR: 12 clinical re-
searchers and 8 expert CF stakeholders) researchers under the supervision of a
methodologist identiﬁed and classiﬁed all the outcomes from the 72 Cochrane
reviews in CF. A list of outcomes was created and thoroughly discussed among
all clinical researchers and CF stakeholders in 4 meetings and via e-mail. Clinical
researchers and CF stakeholders indenpendently ranked the entire list of outcomes
with respect to relevance using a score from 1 (very low) to 9 (very high).
Results: The 72 Cochrane reviews were divided into 10 research areas and
produced a list of 206 outcomes (taking into account synonyms). Clinical re-
searchers tried to classify this list creating for each outcome (e.g. DIOS) a category
(e.g. clinical), a subcategory 1 (e.g. gastroenterology) and a subcategory 2 (e.g.
symptoms/conditions/complications). With respect to patient centered relevance CF
stakeholders and researchers agreed about relevance only for 46/206 outcomes
(22%) while 23/206 (11%) and 25/206 (12%) outcomes are considered not relevant
by researchers and by stakeholders respectively. For 113/206 (55%) outcomes CF
stakeholders and researchers didn’t agree about the relevance.
Conclusion: There are marked differences in the perception of relevance for each
outcome by clinical researchers and CF stakeholders. The results of the IPaCOR’s
outcome ranking method suggests the need to re-classify the outcomes by taking
into account the patients’ perspective.
